The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia

被引:7432
作者
Arber, Daniel A. [1 ]
Orazi, Attilio [2 ]
Hasserjian, Robert [3 ]
Thiele, Jurgen [4 ]
Borowitz, Michael J. [5 ]
Le Beau, Michelle M. [6 ]
Bloomfield, Clara D. [7 ,8 ]
Cazzola, Mario [9 ,10 ]
Vardiman, James W. [11 ]
机构
[1] Stanford Univ, Dept Pathol, 300 Pasteur Dr H1401 M-C 5627, Stanford, CA 94305 USA
[2] Weill Cornell Med Coll, Dept Pathol, New York, NY USA
[3] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA
[4] Univ Cologne, Inst Pathol, Joseph Stelzmann Str 9, Cologne, Germany
[5] Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21205 USA
[6] Univ Chicago, Hematol Oncol Sect, Chicago, IL 60637 USA
[7] Ohio State Univ, Ctr Comprehens Canc, James Canc Hosp, Columbus, OH 43210 USA
[8] Ohio State Univ, Solove Res Inst, Columbus, OH 43210 USA
[9] Univ Pavia, Dept Mol Med, Via Palestro 3, I-27100 Pavia, Italy
[10] Fdn IRCCS Policlin San Matteo, Dept Hematol Oncol, Pavia, Italy
[11] Univ Chicago, Dept Pathol, 5841 S Maryland Ave, Chicago, IL 60637 USA
关键词
ACUTE LYMPHOBLASTIC-LEUKEMIA; SINGLE CEBPA MUTATIONS; CHRONIC MYELOMONOCYTIC LEUKEMIA; INTERMEDIATE-RISK CYTOGENETICS; MYELODYSPLASTIC SYNDROMES MDS; ACUTE ERYTHROID LEUKEMIA; PHENOTYPE ACUTE-LEUKEMIA; ESSENTIAL THROMBOCYTHEMIA; MULTILINEAGE DYSPLASIA; CLONAL HEMATOPOIESIS;
D O I
10.1182/blood-2016-03-643544
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The World Health Organization (WHO) classification of tumors of the hematopoietic and lymphoid tissues was last updated in 2008. Since then, there have been numerous advances in the identification of unique biomarkers associated with some myeloid neoplasms and acute leukemias, largely derived from gene expression analysis and next-generation sequencing that can significantly improve the diagnostic criteria as well as the prognostic relevance of entities currently included in the WHO classification and that also suggest new entities that should be added. Therefore, there is a clear need for a revision to the current classification. The revisions to the categories of myeloid neoplasms and acute leukemia will be published in a monograph in 2016 and reflect a consensus of opinion of hematopathologists, hematologists, oncologists, and geneticists. The 2016 edition represents a revision of the prior classification rather than an entirely new classification and attempts to incorporate new clinical, prognostic, morphologic, immunophenotypic, and genetic data that have emerged since the last edition. The major changes in the classification and their rationale are presented here.
引用
收藏
页码:2391 / 2405
页数:15
相关论文
共 134 条
[51]   The genomic landscape of hypodiploid acute lymphoblastic leukemia [J].
Holmfeldt, Linda ;
Wei, Lei ;
Diaz-Flores, Ernesto ;
Walsh, Michael ;
Zhang, Jinghui ;
Ding, Li ;
Payne-Turner, Debbie ;
Churchman, Michelle ;
Andersson, Anna ;
Chen, Shann-Ching ;
McCastlain, Kelly ;
Becksfort, Jared ;
Ma, Jing ;
Wu, Gang ;
Patel, Samir N. ;
Heatley, Susan L. ;
Phillips, Letha A. ;
Song, Guangchun ;
Easton, John ;
Parker, Matthew ;
Chen, Xiang ;
Rusch, Michael ;
Boggs, Kristy ;
Vadodaria, Bhavin ;
Hedlund, Erin ;
Drenberg, Christina ;
Baker, Sharyn ;
Pei, Deqing ;
Cheng, Cheng ;
Huether, Robert ;
Lu, Charles ;
Fulton, Robert S. ;
Fulton, Lucinda L. ;
Tabib, Yashodhan ;
Dooling, David J. ;
Ochoa, Kerri ;
Minden, Mark ;
Lewis, Ian D. ;
To, L. Bik ;
Marlton, Paula ;
Roberts, Andrew W. ;
Raca, Gordana ;
Stock, Wendy ;
Neale, Geoffrey ;
Drexler, Hans G. ;
Dickins, Ross A. ;
Ellison, David W. ;
Shurtleff, Sheila A. ;
Pui, Ching-Hon ;
Ribeiro, Raul C. .
NATURE GENETICS, 2013, 45 (03) :242-252
[52]   Reply to 'Heterogeneity within AML with CEBPA mutations; only CEBPA double mutations, but not single CEBPA mutations are associated with favorable prognosis' [J].
Hou, H-A ;
Lin, L-I ;
Chen, C-Y ;
Tien, H-F .
BRITISH JOURNAL OF CANCER, 2009, 101 (04) :738-740
[53]   Clinical significance of early T-cell precursor acute lymphoblastic leukaemia: results of the Tokyo Children's Cancer Study Group Study L99-15 [J].
Inukai, Takeshi ;
Kiyokawa, Nobutaka ;
Campana, Dario ;
Coustan-Smith, Elaine ;
Kikuchi, Akira ;
Kobayashi, Miyuki ;
Takahashi, Hiroyuki ;
Koh, Katsuyoshi ;
Manabe, Atsushi ;
Kumagai, Masaaki ;
Ikuta, Koichiro ;
Hayashi, Yasuhide ;
Tsuchida, Masahiro ;
Sugita, Kanji ;
Ohara, Akira .
BRITISH JOURNAL OF HAEMATOLOGY, 2012, 156 (03) :358-365
[54]   Prognostic Score Including Gene Mutations in Chronic Myelomonocytic Leukemia [J].
Itzykson, Raphael ;
Kosmider, Olivier ;
Renneville, Aline ;
Gelsi-Boyer, Veronique ;
Meggendorfer, Manja ;
Morabito, Margot ;
Berthon, Celine ;
Ades, Lionel ;
Fenaux, Pierre ;
Beyne-Rauzy, Odile ;
Vey, Norbert ;
Braun, Thorsten ;
Haferlach, Torsten ;
Dreyfus, Francois ;
Cross, Nicholas C. P. ;
Preudhomme, Claude ;
Bernard, Olivier A. ;
Fontenay, Michaela ;
Vainchenker, William ;
Schnittger, Susanne ;
Birnbaum, Daniel ;
Droin, Nathalie ;
Solary, Eric .
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (19) :2428-+
[55]   Chronic myeloid leukemia: 2014 update on diagnosis, monitoring, and management [J].
Jabbour, Elias ;
Kantarjian, Hagop .
AMERICAN JOURNAL OF HEMATOLOGY, 2014, 89 (05) :547-556
[56]   TP53 Mutations in Low-Risk Myelodysplastic Syndromes With del(5q) Predict Disease Progression [J].
Jaedersten, Martin ;
Saft, Leonie ;
Smith, Alexander ;
Kulasekararaj, Austin ;
Pomplun, Sabine ;
Goehring, Gudrun ;
Hedlund, Anette ;
Hast, Robert ;
Schlegelberger, Brigitte ;
Porwit, Anna ;
Hellstrom-Lindberg, Eva ;
Mufti, Ghulam J. .
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15) :1971-1979
[57]   Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes [J].
Jaiswal, Siddhartha ;
Fontanillas, Pierre ;
Flannick, Jason ;
Manning, Alisa ;
Grauman, Peter V. ;
Mar, Brenton G. ;
Lindsley, R. Coleman ;
Mermel, Craig H. ;
Burtt, Noel ;
Chavez, Alejandro ;
Higgins, John M. ;
Moltchanov, Vladislav ;
Kuo, Frank C. ;
Kluk, Michael J. ;
Henderson, Brian ;
Kinnunen, Leena ;
Koistinen, Heikki A. ;
Ladenvall, Claes ;
Getz, Gad ;
Correa, Adolfo ;
Banahan, Benjamin F. ;
Gabriel, Stacey ;
Kathiresan, Sekar ;
Stringham, Heather M. ;
McCarthy, Mark I. ;
Boehnke, Michael ;
Tuomilehto, Jaakko ;
Haiman, Christopher ;
Groop, Leif ;
Atzmon, Gil ;
Wilson, James G. ;
Neuberg, Donna ;
Altshuler, David ;
Ebert, Benjamin L. .
NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (26) :2488-2498
[58]   Successful treatment of Philadelphia chromosome-positive mixed phenotype acute leukemia by appropriate alternation of second-generation tyrosine kinase inhibitors according to BCR-ABL1 mutation status [J].
Kawajiri, Chika ;
Tanaka, Hiroaki ;
Hashimoto, Shinichiro ;
Takeda, Yusuke ;
Sakai, Shio ;
Takagi, Toshiyuki ;
Takeuchi, Masahiro ;
Ohwada, Chikako ;
Sakaida, Emiko ;
Shimizu, Naomi ;
Nakaseko, Chiaki .
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2014, 99 (04) :513-518
[59]   Molecular characterization of de novo Philadelphia chromosome-positive acute myeloid leukemia [J].
Konoplev, Sergej ;
Yin, C. Cameron ;
Kornblau, Steven M. ;
Kantarjian, Hagop M. ;
Konopleva, Marina ;
Andreeff, Michael ;
Lu, Gary ;
Zuo, Zhuang ;
Luthra, Rajyalakshmi ;
Medeiros, L. Jeffrey ;
Bueso-Ramos, Carlos E. .
LEUKEMIA & LYMPHOMA, 2013, 54 (01) :138-144
[60]   MDS-associated somatic mutations and clonal hematopoiesis are common in idiopathic cytopenias of undetermined significance [J].
Kwok, Brian ;
Hall, Jeff M. ;
Witte, John S. ;
Xu, Yin ;
Reddy, Prashanti ;
Lin, Keming ;
Flamholz, Rachel ;
Dabbas, Bashar ;
Yung, Aine ;
Al-Hafidh, Jenan ;
Balmert, Emily ;
Vaupel, Christine ;
El Hader, Carlos ;
McGinniss, Matthew J. ;
Nahas, Shareef A. ;
Kines, Julie ;
Bejar, Rafael .
BLOOD, 2015, 126 (21) :2355-2361